|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
IMVT | Macias William L. | Chief Medical Officer | Apr 17 | Sale | 29.06 | 8,280 | 240,602 | 377,650 | Apr 19 06:05 PM |
IMVT | Macias William L. | Chief Medical Officer | Feb 22 | Sale | 36.15 | 2,221 | 80,289 | 330,952 | Feb 23 04:16 PM |
IMVT | Macias William L. | Chief Medical Officer | Jan 18 | Sale | 41.03 | 424 | 17,397 | 333,173 | Jan 19 04:04 PM |
IMVT | Macias William L. | Chief Medical Officer | Nov 22 | Sale | 32.78 | 3,265 | 107,024 | 333,597 | Nov 24 02:45 PM |
IMVT | Macias William L. | Chief Medical Officer | Oct 19 | Sale | 36.80 | 530 | 19,504 | 336,862 | Oct 20 04:06 PM |
IMVT | Macias William L. | Chief Medical Officer | Aug 24 | Sale | 20.30 | 12,333 | 250,360 | 337,392 | Aug 25 04:57 PM |
IMVT | Macias William L. | Chief Medical Officer | Jul 19 | Sale | 24.94 | 426 | 10,624 | 349,725 | Jul 20 04:37 PM |
IMVT | Macias William L. | Chief Medical Officer | Apr 25 | Sale | 16.29 | 509 | 8,292 | 350,151 | Apr 26 04:12 PM |
IMVT | Macias William L. | Chief Medical Officer | Feb 02 | Sale | 18.24 | 537 | 9,795 | 262,996 | Feb 03 07:24 AM |
IMVT | Macias William L. | Chief Medical Officer | Jan 11 | Sale | 16.75 | 44,568 | 746,317 | 263,533 | Jan 13 08:13 AM |
IMVT | Macias William L. | Chief Medical Officer | Oct 21 | Sale | 9.67 | 341 | 3,297 | 308,101 | Oct 25 07:43 AM |
IMVT | Macias William L. | Chief Medical Officer | Jul 22 | Sale | 4.70 | 322 | 1,513 | 195,626 | Jul 26 07:35 AM |
IMVT | Macias William L. | Chief Medical Officer | Apr 19 | Sale | 4.98 | 1,392 | 6,932 | 195,948 | Apr 20 04:34 PM |
IMVT | Macias William L. | Chief Medical Officer | Jan 05 | Sale | 8.28 | 26,813 | 222,012 | 197,340 | Jan 07 12:39 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite